Term
|
Definition
Quinacrine banding: use fluorescent microscope to band chromosomes; replaced by G-banding |
|
|
Term
|
Definition
Giemsa banding: partially digest chromosome proteins with trypsin before staining
400-800 bands/chromosome |
|
|
Term
|
Definition
Reverse banding: use heat treatment; reverses the black and white color; particularly good for the distal end of chromosomes |
|
|
Term
|
Definition
Visualize the constitutive heterochromatin near centromeres |
|
|
Term
|
Definition
Nucleolar Organizing Region stains: stains the satellite and stalk of acrocentric chromosomes |
|
|
Term
|
Definition
Stain the chromosome in prophase or pre-metaphase to identify more, particularly less obvious abnormalities |
|
|
Term
Fluorescent In Situ Hybridization (FISH) |
|
Definition
Use a DNA probe marked with fluorescent dye to hybridize with and identify chromosomes; better than high resolution banding and can identify a 1 million base pair deletion
Detects: extra chromosomes, deleted chromosomes, chromosomal rearrangement |
|
|
Term
|
Definition
Uses combinations of 5 dyes to color all the chromosome
Useful identifying small chromosome rearrangements |
|
|
Term
Comparative Genomic Hybridization (CGH) |
|
Definition
1) Extract DNA from test source 2) Label DNA with a color (red) 3) Label DNA from control with a different color (green) 4) Allow both to hybridize with normal metaphase chromosomes Red = chromosome duplication Green = chromosome deletion
Limitation: can't detect deletions or duplications less than 5-10 million bp |
|
|
Term
|
Definition
Same as CGH except test and control DNA is hybridized with a microarray and probes for specific areas of a chromosome
Detects 1 million bp things Can't see things less than 150,000 bp unless a smaller probe is used
*Can't detect balanced rearrangements |
|
|
Term
PCR- Polymerase Chain Reaction |
|
Definition
Amplification of DNA so you can later perform many cytogenetic tests on the amplified DNA |
|
|
Term
Direct Detection of DNA Alterations |
|
Definition
Sequence the DNA, then compare it to a known wild-type DNA sequence to detect mutations
*Use when the alteration for the given disease is known |
|
|
Term
Microarray-based DNA sequencing |
|
Definition
Oligonucleotides for wild-type and mutation sequence are "tiled," labeled with fluorescent dye, and the array is tested for hybridization.
Strong signal = that sequence, and computerized algorithms decode the DNA sequence based on the fluorescent hybridization pattern. |
|
|
Term
|
Definition
Indirect approach
These enzymes recognize and cut DNA at specific sequences. If a mutation occurs at a restriction site, add the restriction enzyme, amplify DNA with PCR, and you get two different sized fragments- the mutant one is weird and the normal one is normal sized.
If you run it on agarose gel electrophoresis, the bands travel different distances.
*Use when mutation occurs at an invariable place. |
|
|
Term
Fluorescent Labels in PCR mixture |
|
Definition
Indirect Method
Add fluorescently labeled nucleotides to the mix. The normal sequence will have the correctly incorporated base, whereas the mutant will incorporate a different base.
*Can detect mutant DNA in heterogenous mixtures of normal and abnormal cells
*Use on prenatal samples, peripheral blood lymphocytes, cancer biopsies, tissue sections *Use to detect chromosomal abnormalities, microdeletions, translocations, gene amplification, mapping newly isolated genes of interest |
|
|
Term
|
Definition
Indirect Method
Use fluorophores in "real time" so you don't have to digest fragments and do elecctrophoresis- save time! |
|
|
Term
|
Definition
Add primers that go on either side of a known segment that would have variable size, like Fragile X. The PCR products will be variable sizes, and you can determine the problem- size difference determined by running products on gel |
|
|
Term
|
Definition
Assesing a marker loci in family members having the disease or trait of interest, assuming the marker loci is close to the disease allele transmitted through pedigrees
*Use if you don't know what the gene is, prenatal and presymptomatic diagnosis, or several different mutations cause the diseased state |
|
|
Term
|
Definition
Genetic marker that can be followed from parent to child
- prevalent throughout genome and stable
*Used in linkage analysis for identifying haplotypes associated with disease |
|
|
Term
Repeat-length polymorphisms |
|
Definition
Short repetitive sequences of DNA
Microsatellite repeats: <1000 bp, 2-6 bp repeat size *Ideal for differentiating two individuals and following transmission of markers from parent to child Minisatellite repeats: 1000-3000 bp repeats, repeat motif of 15-70 bp |
|
|
Term
Genome-Wide Association Studies (GWAS) |
|
Definition
Large number of patients have their genomes examined for variants, which allows the identification of variable areas in the genome or areas where a disease is likely to occur- the candidate gene |
|
|
Term
|
Definition
Hybridize radiolabeled sequence-specific probes to genomic DNA that was digested with a restriction enzyme and separated by gel electrophoresis- need a normal control
*Use to detect changes in the structure of specific loci *Use for large trinucleotide expansion diseases (Fragile X) and clonal Ig gene rearrangements (lymphoma) |
|
|
Term
Array Comparative Genomic Hybridization (CGH) |
|
Definition
Label normal and test samples with dye (CY5 and CY3), hybridize samples with DNA probe- equal expression = yellow, overproduction of mutation is red (CY3) meaning duplication, underproduction is green (CY5) meaning deletion
*Use to detect abnormalities without prior knowledge of the problem
*Localizes amplifications and deletions in the test sample |
|
|
Term
|
Definition
Study of heritable chemical modifications of DNA or chromatin without altering the DNA sequence- DNA methylation, histone methylation and acetylation |
|
|
Term
Sodium Bisulfite Treatment |
|
Definition
Treat DNA with this, converts unmethylated cytosines to uracil, methylation-specific PCR is then performed |
|
|